Clinical Trials Browser

Phase 2 × Breast Neoplasms × Lisinopril × Clear all

NCT01009918 2021-03-30

Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab

Phase 2 Completed

468 enrolled 16 charts

Breast Neoplasms, Breast Neoplasms, Male, Cardiotoxicity